Avanos Medical, Inc. announced the acquisition of Nexus Medical, LLC.
Nexus Medical is known for the TKO ® anti-reflux needleless connector technology.
The acquisition enhances Avanos' focus on safe therapy delivery in high-acuity settings like NICUs and PICUs.
Strategic Acquisition
Avanos acquired Nexus Medical to enhance nutrition and medication delivery in critical care settings.
Innovative Technology
The TKO ® needleless connector by Nexus minimizes blood reflux, reducing therapy delays and infection risks.
Immediate Value
The acquisition is expected to be immediately accretive to Avanos' revenue growth and earnings per share.
- The acquisition aligns with Avanos' strategy to provide smarter and safer solutions in critical care.
- The addition of Nexus Medical's technology strengthens Avanos' Specialty Nutrition Systems business.
- The TKO ® connector is designed to streamline therapy delivery and improve patient outcomes in neonatal care.
Avanos Medical's acquisition of Nexus Medical demonstrates its commitment to innovation and patient safety in critical care settings.